Worth Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Worth Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$12.7K	–	233
2023 Q2	$12.7K	Hold	100	–	–	0.01%	277
2023 Q1	$12.9K	Sell	100 -10,525	-99%	-$1.38M	0.01%	301
2022 Q4	$1.39M	Buy	10,625 +10,465	+6,541%	+$1.35M	0.97%	24
2022 Q3	$19K	Hold	160	–	–	0.01%	226
2022 Q2	$19K	Hold	160	–	–	0.01%	301
2022 Q1	$18K	Buy	+160	New	+$20.8K	0.01%	311

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Worth Asset Management's IBB Position: Q3 2023 in Review

Worth Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 100 shares — an estimated $12.7K sold.

Worth Asset Management first reported a position in IBB in Q1 2022 and held it in 6 quarters. The position peaked at $1.39M in Q4 2022. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Worth Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 100 iShares Biotechnology ETF shares in Q3 2023, an estimated $12.7K.
Worth Asset Management first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 6 quarters.
Worth Asset Management's iShares Biotechnology ETF position peaked at $1.39M in Q4 2022.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.